HCV
WHO Prequalifies First Self-Test for Hepatitis C
A professional-use version of the OraSure Technologies OraQuick, a rapid antibody test, was prequalified in 2017.
The firm provided updates on its business while it undergoes an internal strategic review process aimed at enhancing shareholder value.
Genedrive Expects CE-IVD Mark for POC SARS-CoV-2 Test by Fall; Advances Hearing Loss, HCV Assays
Premium
The Manchester, UK-based company had previously planned to have a CE-IVD marked test out by June 30.
BioLytical Laboratories Obtains CE Mark for One-Minute HCV Antibody Test
The firm said that the test is 99 percent accurate and runs on its Insti platform, which performs antibody testing from fingerstick whole-blood samples.
OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate
The firm attributed its quarterly and annual revenue gains primarily to sales of COVID-19 testing sample collection devices.
Feb 19, 2020
OraSure Technologies Q4 Revenues Down 1 Percent
Oct 15, 2019
Enzo Biochem Fiscal Q4 Revenues Down 8 Percent
Aug 6, 2019
OraSure Technologies Q2 Revenues Down 11 Percent
Jun 25, 2019
NeuMoDx Gets CE Mark on Hepatitis B and C Assays
May 8, 2019
OraSure Technologies Q1 Revenues Down 28 Percent
Apr 25, 2019
Feb 6, 2019
OraSure Technologies Q4 Revenues Down 3 Percent
Dec 18, 2018
Systaaq HBV Assay Receives CE Mark
Nov 7, 2018